A Novel Approach to Precision Oncology

  • We are unlocking post-translational modification of proteins by utilizing our state-of-the-art chemical biology and computational approaches, and combining with inhibition at key metabolic nodes to generate drugs for previously considered undruggable targets.
  • Tasca is focused on using its proprietary platform to develop small molecule drugs for hard-to-treat oncology indications.